ERBB2 and neoplasm: Moreover, the results of this study cannot be applied to subsets of patients like young women (<50 years), patients undergoing mastectomy, patients with lobular carcinoma or hormone receptor negative tumours or HER2 positive tumours, due to being underrepresented in Z0011 study.